Literature DB >> 3010649

Interstitial 125I implantation in the retreatment of retroperitoneal soft tissue sarcoma. Report of a case.

P P Kumar, R R Good.   

Abstract

Interstitial 125I was successfully used in the retreatment of a large recurrent malignant schwannoma in the retroperitoneum. After an average tumor dose of 160 Gy the tumor calcified and the patient is well, without disease 2 years later.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3010649     DOI： 10.3109/02841868609136375

Source DB:  PubMed          Journal:  Acta Radiol Oncol        ISSN： 0349-652X


  3 in total

1.  Survival of patients with unresectable non-small cell lung cancer following 6,000 rad megavoltage radiotherapy.

Authors:  P P Kumar; R R Good; P R Hynes; S H Plantz; J E Somers; B E McAnulty; G F McCaul; S S Rogers; M A Reeves
Journal:  J Natl Med Assoc       Date:  1987-03       Impact factor: 1.798

2.  CT-guided 125I seed implantation for inoperable retroperitoneal sarcoma: A technique for delivery of local tumor brachytherapy.

Authors:  Biao Yang; Wen-Hao Guo; Ting Lan; Fang Yuan; Guan-Jian Liu; Rui-Yu Zan; Xin You; Qiao-Yue Tan; Zheng-Yin Liao
Journal:  Exp Ther Med       Date:  2016-11-14       Impact factor: 2.447

3.  Definitive Radiotherapy in the Management of Non-Resectable or Residual Retroperitoneal Sarcomas: Institutional Cohort Analysis and Systematic Review.

Authors:  Aleksandra Sobiborowicz; Mateusz Jacek Spałek; Anna Małgorzata Czarnecka; Piotr Rutkowski
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.